Probable ponatinib-induced papilledema in a patient with acute lymphocytic leukemia

Bilateral optic disc edema as a possible complication of cabozantinib use–a case report

(2022) Yu-Te Huang et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Making the case for the case report – informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients

(2022) Nechama J. Lipton et al.   LEUKEMIA & LYMPHOMA

Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia

(2022) Fadi Haddad et al.   LEUKEMIA & LYMPHOMA

Ponatinib Inducing a Panuveitis with Choroidal Effusions and Neurosensory Retinal Detachment in a Patient with Chronic Myeloid Leukaemia

(2021) A. D. Patil et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Ponatinib Dose-Ranging Study in Chronic-Phase Chronic Myeloid Leukemia: A Randomized, Open-Label Phase 2 Clinical Trial

(2021) Jorge Cortes et al.   BLOOD

Papilledema and intracranial hypertension in leukemia: case series report and review

(2021) Alvaro J. Mejia-Vergara et al.   CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Papilledema: A review of etiology, pathophysiology, diagnosis, and management

(2021) Jim Shenchu Xie et al.   SURVEY OF OPHTHALMOLOGY

Neuro-ophthalmic side effects of molecularly targeted cancer drugs

(2017) M T Bhatti et al.   EYE

Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children

(2013) D. I. Friedman et al.   NEUROLOGY

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

(2013) J.E. Cortes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Imatinib Mesylate (Gleevec) Induced Unilateral Optic Disc Edema

(2012) Crystal DeLuca et al.   OPTOMETRY AND VISION SCIENCE

Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma

(2010) Jaclyn Yoong et al.   MEDICAL ONCOLOGY

AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

(2009) Thomas O'Hare et al.   CANCER CELL

Optic disc edema as a possible complication of Imatinib mesylate (Gleevec)

(2008) Soon-Il Kwon et al.   JAPANESE JOURNAL OF OPHTHALMOLOGY